Activities for the Development of Targeted Radionuclide Therapy in Japan View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-12-15

AUTHORS

Seigo Kinuya

ABSTRACT

Targeted radionuclide therapy (TRT) is unique because of its efficacy and its theranostic feature in the era of precision medicine. So far, introduction of new TRT has not been going well in Japan due to several reasons including strict regulations, shortage of facilities for TRT, and insufficient reimbursement for TRT in clinic. Japanese community had several strategies to develop TRT in these 10 years, including the establishment of the National Conference for Nuclear Medicine Theranostics in which physicians, scientists, patients, people supporting patients, and industrial people gather. To promote TRT with supports from the government, the preparatory committee for the establishment of Japan Foundation of Medical Isotope Development (JAFMID) was launched. I would like to call TRT “Precision Nuclear Medicine.” When we can add genomic information here, we can put it to new stage of cancer therapy. It is time for us. More... »

PAGES

35-37

References to SciGraph publications

  • 2018-01-15. Manual on the proper use of lutetium-177-labeled somatostatin analogue (Lu-177-DOTA-TATE) injectable in radionuclide therapy (2nd ed.) in ANNALS OF NUCLEAR MEDICINE
  • 2018-07-13. Prognostic value of 68 Ga PSMA I&T PET/CT SUV parameters on survival outcome in advanced prostat cancer in ANNALS OF NUCLEAR MEDICINE
  • <error retrieving object. in <ERROR RETRIEVING OBJECT
  • 2017-03-18. Long-term results and tolerability of tandem peptide receptor radionuclide therapy with 90Y/177Lu-DOTATATE in neuroendocrine tumors with respect to the primary location: a 10-year study in ANNALS OF NUCLEAR MEDICINE
  • 2012-03-27. Thyroid remnant ablation using 1,110 MBq of I-131 after total thyroidectomy: regulatory considerations on release of patients after unsealed radioiodine therapy in ANNALS OF NUCLEAR MEDICINE
  • 2018-09-20. Clinical feasibility of early scanning after administration of 68Ga-DOTATOC in ANNALS OF NUCLEAR MEDICINE
  • 2018-01-18. The influence of elevated hormone levels on physiologic accumulation of 68Ga-DOTATOC in ANNALS OF NUCLEAR MEDICINE
  • 2018-05-23. Radiation exposure after 177Lu-DOTATATE and 177Lu-PSMA-617 therapy in ANNALS OF NUCLEAR MEDICINE
  • 2018-08-14. Molecular imaging reporting and data systems (MI-RADS): a generalizable framework for targeted radiotracers with theranostic implications in ANNALS OF NUCLEAR MEDICINE
  • 2018-11-07. Phase I/IIa PET imaging study with 89zirconium labeled anti-PSMA minibody for urological malignancies in ANNALS OF NUCLEAR MEDICINE
  • 2018-07-07. Reproducibility of standardized uptake values of same-day randomized 68Ga-PSMA-11 PET/CT and PET/MR scans in recurrent prostate cancer patients in ANNALS OF NUCLEAR MEDICINE
  • 2018-08-13. CXCR4-directed theranostics in oncology and inflammation in ANNALS OF NUCLEAR MEDICINE
  • 2017-08-22. Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted 18F-DCFPyL in peripheral ganglia in ANNALS OF NUCLEAR MEDICINE
  • 2017-09-12. Relationships between serum PSA levels, Gleason scores and results of 68Ga-PSMAPET/CT in patients with recurrent prostate cancer in ANNALS OF NUCLEAR MEDICINE
  • 2015-03-14. Draft guidelines regarding appropriate use of 131I-MIBG radiotherapy for neuroendocrine tumors in ANNALS OF NUCLEAR MEDICINE
  • 2018-01-19. Antitumor effects of radionuclide treatment using α-emitting meta-211At-astato-benzylguanidine in a PC12 pheochromocytoma model in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2018-02-21. 68Ga-DOTATATE PET–CT imaging in carotid body paragangliomas in ANNALS OF NUCLEAR MEDICINE
  • 2017-10-24. Low levels of PSMA expression limit the utility of 18F-DCFPyL PET/CT for imaging urothelial carcinoma in ANNALS OF NUCLEAR MEDICINE
  • 2018-07-26. Large cell neuroendocrine carcinoma of the lung with atypical evolution and a remarkable response to lutetium Lu 177 dotatate in ANNALS OF NUCLEAR MEDICINE
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s13139-018-0563-4

    DOI

    http://dx.doi.org/10.1007/s13139-018-0563-4

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1110668571

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/30828398


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/02", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Physical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0299", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Other Physical Sciences", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takaramachi, 920-8641, Kanazawa, Ishikawa, Japan", 
              "id": "http://www.grid.ac/institutes/grid.412002.5", 
              "name": [
                "Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takaramachi, 920-8641, Kanazawa, Ishikawa, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kinuya", 
            "givenName": "Seigo", 
            "id": "sg:person.0620177742.17", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620177742.17"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s12149-018-1290-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1106125946", 
              "https://doi.org/10.1007/s12149-018-1290-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-017-1207-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1091594397", 
              "https://doi.org/10.1007/s12149-017-1207-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-017-1163-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1084034239", 
              "https://doi.org/10.1007/s12149-017-1163-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-017-1216-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1092351426", 
              "https://doi.org/10.1007/s12149-017-1216-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-017-3919-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1100478294", 
              "https://doi.org/10.1007/s00259-017-3919-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-015-0960-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006620729", 
              "https://doi.org/10.1007/s12149-015-0960-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-018-1317-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1110227037", 
              "https://doi.org/10.1007/s12149-018-1317-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-018-1264-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1104152081", 
              "https://doi.org/10.1007/s12149-018-1264-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-018-1312-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1109759418", 
              "https://doi.org/10.1007/s12149-018-1312-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-018-1276-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1105856637", 
              "https://doi.org/10.1007/s12149-018-1276-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-017-1201-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1091287901", 
              "https://doi.org/10.1007/s12149-017-1201-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-018-1242-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1101142948", 
              "https://doi.org/10.1007/s12149-018-1242-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-018-1230-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1100399578", 
              "https://doi.org/10.1007/s12149-018-1230-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-012-0590-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038929936", 
              "https://doi.org/10.1007/s12149-012-0590-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-018-1291-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1106150181", 
              "https://doi.org/10.1007/s12149-018-1291-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-018-1275-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1105345400", 
              "https://doi.org/10.1007/s12149-018-1275-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-018-1304-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1107121645", 
              "https://doi.org/10.1007/s12149-018-1304-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-018-1277-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1105568984", 
              "https://doi.org/10.1007/s12149-018-1277-5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12149-018-1233-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1100471058", 
              "https://doi.org/10.1007/s12149-018-1233-4"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2018-12-15", 
        "datePublishedReg": "2018-12-15", 
        "description": "Targeted radionuclide therapy (TRT) is unique because of its efficacy and its theranostic feature in the era of precision medicine. So far, introduction of new TRT has not been going well in Japan due to several reasons including strict regulations, shortage of facilities for TRT, and insufficient reimbursement for TRT in clinic. Japanese community had several strategies to develop TRT in these 10\u00a0years, including the establishment of the National Conference for Nuclear Medicine Theranostics in which physicians, scientists, patients, people supporting patients, and industrial people gather. To promote TRT with supports from the government, the preparatory committee for the establishment of Japan Foundation of Medical Isotope Development (JAFMID) was launched. I would like to call TRT \u201cPrecision Nuclear Medicine.\u201d When we can add genomic information here, we can put it to new stage of cancer therapy. It is time for us.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s13139-018-0563-4", 
        "inLanguage": "en", 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.5904522", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1016285", 
            "issn": [
              "1869-3474", 
              "1869-3482"
            ], 
            "name": "Nuclear Medicine and Molecular Imaging", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "53"
          }
        ], 
        "keywords": [
          "targeted radionuclide therapy", 
          "radionuclide therapy", 
          "insufficient reimbursement", 
          "therapy", 
          "cancer therapy", 
          "shortage of facilities", 
          "patients", 
          "Japanese community", 
          "precision medicine", 
          "nuclear medicine", 
          "medicine", 
          "clinic", 
          "physicians", 
          "efficacy", 
          "reimbursement", 
          "National Conference", 
          "people", 
          "years", 
          "development", 
          "activity", 
          "Committee", 
          "regulation", 
          "Japan", 
          "theranostic features", 
          "establishment", 
          "stage", 
          "strict regulations", 
          "support", 
          "strategies", 
          "reasons", 
          "time", 
          "facilities", 
          "features", 
          "shortage", 
          "era", 
          "theranostics", 
          "genomic information", 
          "information", 
          "introduction", 
          "conference", 
          "community", 
          "industrial people", 
          "Preparatory Committee", 
          "foundation", 
          "scientists", 
          "new stage", 
          "Japan Foundation", 
          "government", 
          "new TRT", 
          "Nuclear Medicine Theranostics", 
          "Medicine Theranostics", 
          "Medical Isotope Development", 
          "Isotope Development", 
          "Precision Nuclear Medicine"
        ], 
        "name": "Activities for the Development of Targeted Radionuclide Therapy in Japan", 
        "pagination": "35-37", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1110668571"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s13139-018-0563-4"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "30828398"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s13139-018-0563-4", 
          "https://app.dimensions.ai/details/publication/pub.1110668571"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2021-11-01T18:32", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/article/article_769.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s13139-018-0563-4"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13139-018-0563-4'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13139-018-0563-4'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13139-018-0563-4'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13139-018-0563-4'


     

    This table displays all metadata directly associated to this object as RDF triples.

    194 TRIPLES      22 PREDICATES      99 URIs      72 LITERALS      7 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s13139-018-0563-4 schema:about anzsrc-for:02
    2 anzsrc-for:0299
    3 schema:author Nd9aeb213c14943a19715457843b5a60c
    4 schema:citation sg:pub.10.1007/s00259-017-3919-6
    5 sg:pub.10.1007/s12149-012-0590-7
    6 sg:pub.10.1007/s12149-015-0960-z
    7 sg:pub.10.1007/s12149-017-1163-6
    8 sg:pub.10.1007/s12149-017-1201-4
    9 sg:pub.10.1007/s12149-017-1207-y
    10 sg:pub.10.1007/s12149-017-1216-x
    11 sg:pub.10.1007/s12149-018-1230-7
    12 sg:pub.10.1007/s12149-018-1233-4
    13 sg:pub.10.1007/s12149-018-1242-3
    14 sg:pub.10.1007/s12149-018-1264-x
    15 sg:pub.10.1007/s12149-018-1275-7
    16 sg:pub.10.1007/s12149-018-1276-6
    17 sg:pub.10.1007/s12149-018-1277-5
    18 sg:pub.10.1007/s12149-018-1290-8
    19 sg:pub.10.1007/s12149-018-1291-7
    20 sg:pub.10.1007/s12149-018-1304-6
    21 sg:pub.10.1007/s12149-018-1312-6
    22 sg:pub.10.1007/s12149-018-1317-1
    23 schema:datePublished 2018-12-15
    24 schema:datePublishedReg 2018-12-15
    25 schema:description Targeted radionuclide therapy (TRT) is unique because of its efficacy and its theranostic feature in the era of precision medicine. So far, introduction of new TRT has not been going well in Japan due to several reasons including strict regulations, shortage of facilities for TRT, and insufficient reimbursement for TRT in clinic. Japanese community had several strategies to develop TRT in these 10 years, including the establishment of the National Conference for Nuclear Medicine Theranostics in which physicians, scientists, patients, people supporting patients, and industrial people gather. To promote TRT with supports from the government, the preparatory committee for the establishment of Japan Foundation of Medical Isotope Development (JAFMID) was launched. I would like to call TRT “Precision Nuclear Medicine.” When we can add genomic information here, we can put it to new stage of cancer therapy. It is time for us.
    26 schema:genre article
    27 schema:inLanguage en
    28 schema:isAccessibleForFree true
    29 schema:isPartOf N3833500082334478bf51e0983b76b033
    30 Na3c3d44597da4bfd8a2000c65aa1836f
    31 sg:journal.1016285
    32 schema:keywords Committee
    33 Isotope Development
    34 Japan
    35 Japan Foundation
    36 Japanese community
    37 Medical Isotope Development
    38 Medicine Theranostics
    39 National Conference
    40 Nuclear Medicine Theranostics
    41 Precision Nuclear Medicine
    42 Preparatory Committee
    43 activity
    44 cancer therapy
    45 clinic
    46 community
    47 conference
    48 development
    49 efficacy
    50 era
    51 establishment
    52 facilities
    53 features
    54 foundation
    55 genomic information
    56 government
    57 industrial people
    58 information
    59 insufficient reimbursement
    60 introduction
    61 medicine
    62 new TRT
    63 new stage
    64 nuclear medicine
    65 patients
    66 people
    67 physicians
    68 precision medicine
    69 radionuclide therapy
    70 reasons
    71 regulation
    72 reimbursement
    73 scientists
    74 shortage
    75 shortage of facilities
    76 stage
    77 strategies
    78 strict regulations
    79 support
    80 targeted radionuclide therapy
    81 theranostic features
    82 theranostics
    83 therapy
    84 time
    85 years
    86 schema:name Activities for the Development of Targeted Radionuclide Therapy in Japan
    87 schema:pagination 35-37
    88 schema:productId N404b736c6b5941958556f21e7568255e
    89 Nd095b145907d4fec85860f84b805cfab
    90 Nf3069a44e94f4c8398e608bc7a35dd81
    91 schema:sameAs https://app.dimensions.ai/details/publication/pub.1110668571
    92 https://doi.org/10.1007/s13139-018-0563-4
    93 schema:sdDatePublished 2021-11-01T18:32
    94 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    95 schema:sdPublisher Nc3d9e9c757f24a5d8e9ad3c5b307d9fa
    96 schema:url https://doi.org/10.1007/s13139-018-0563-4
    97 sgo:license sg:explorer/license/
    98 sgo:sdDataset articles
    99 rdf:type schema:ScholarlyArticle
    100 N3833500082334478bf51e0983b76b033 schema:volumeNumber 53
    101 rdf:type schema:PublicationVolume
    102 N404b736c6b5941958556f21e7568255e schema:name dimensions_id
    103 schema:value pub.1110668571
    104 rdf:type schema:PropertyValue
    105 Na3c3d44597da4bfd8a2000c65aa1836f schema:issueNumber 1
    106 rdf:type schema:PublicationIssue
    107 Nc3d9e9c757f24a5d8e9ad3c5b307d9fa schema:name Springer Nature - SN SciGraph project
    108 rdf:type schema:Organization
    109 Nd095b145907d4fec85860f84b805cfab schema:name pubmed_id
    110 schema:value 30828398
    111 rdf:type schema:PropertyValue
    112 Nd9aeb213c14943a19715457843b5a60c rdf:first sg:person.0620177742.17
    113 rdf:rest rdf:nil
    114 Nf3069a44e94f4c8398e608bc7a35dd81 schema:name doi
    115 schema:value 10.1007/s13139-018-0563-4
    116 rdf:type schema:PropertyValue
    117 anzsrc-for:02 schema:inDefinedTermSet anzsrc-for:
    118 schema:name Physical Sciences
    119 rdf:type schema:DefinedTerm
    120 anzsrc-for:0299 schema:inDefinedTermSet anzsrc-for:
    121 schema:name Other Physical Sciences
    122 rdf:type schema:DefinedTerm
    123 sg:grant.5904522 http://pending.schema.org/fundedItem sg:pub.10.1007/s13139-018-0563-4
    124 rdf:type schema:MonetaryGrant
    125 sg:journal.1016285 schema:issn 1869-3474
    126 1869-3482
    127 schema:name Nuclear Medicine and Molecular Imaging
    128 schema:publisher Springer Nature
    129 rdf:type schema:Periodical
    130 sg:person.0620177742.17 schema:affiliation grid-institutes:grid.412002.5
    131 schema:familyName Kinuya
    132 schema:givenName Seigo
    133 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620177742.17
    134 rdf:type schema:Person
    135 sg:pub.10.1007/s00259-017-3919-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100478294
    136 https://doi.org/10.1007/s00259-017-3919-6
    137 rdf:type schema:CreativeWork
    138 sg:pub.10.1007/s12149-012-0590-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038929936
    139 https://doi.org/10.1007/s12149-012-0590-7
    140 rdf:type schema:CreativeWork
    141 sg:pub.10.1007/s12149-015-0960-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1006620729
    142 https://doi.org/10.1007/s12149-015-0960-z
    143 rdf:type schema:CreativeWork
    144 sg:pub.10.1007/s12149-017-1163-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084034239
    145 https://doi.org/10.1007/s12149-017-1163-6
    146 rdf:type schema:CreativeWork
    147 sg:pub.10.1007/s12149-017-1201-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091287901
    148 https://doi.org/10.1007/s12149-017-1201-4
    149 rdf:type schema:CreativeWork
    150 sg:pub.10.1007/s12149-017-1207-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1091594397
    151 https://doi.org/10.1007/s12149-017-1207-y
    152 rdf:type schema:CreativeWork
    153 sg:pub.10.1007/s12149-017-1216-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1092351426
    154 https://doi.org/10.1007/s12149-017-1216-x
    155 rdf:type schema:CreativeWork
    156 sg:pub.10.1007/s12149-018-1230-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100399578
    157 https://doi.org/10.1007/s12149-018-1230-7
    158 rdf:type schema:CreativeWork
    159 sg:pub.10.1007/s12149-018-1233-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100471058
    160 https://doi.org/10.1007/s12149-018-1233-4
    161 rdf:type schema:CreativeWork
    162 sg:pub.10.1007/s12149-018-1242-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101142948
    163 https://doi.org/10.1007/s12149-018-1242-3
    164 rdf:type schema:CreativeWork
    165 sg:pub.10.1007/s12149-018-1264-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1104152081
    166 https://doi.org/10.1007/s12149-018-1264-x
    167 rdf:type schema:CreativeWork
    168 sg:pub.10.1007/s12149-018-1275-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105345400
    169 https://doi.org/10.1007/s12149-018-1275-7
    170 rdf:type schema:CreativeWork
    171 sg:pub.10.1007/s12149-018-1276-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105856637
    172 https://doi.org/10.1007/s12149-018-1276-6
    173 rdf:type schema:CreativeWork
    174 sg:pub.10.1007/s12149-018-1277-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105568984
    175 https://doi.org/10.1007/s12149-018-1277-5
    176 rdf:type schema:CreativeWork
    177 sg:pub.10.1007/s12149-018-1290-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106125946
    178 https://doi.org/10.1007/s12149-018-1290-8
    179 rdf:type schema:CreativeWork
    180 sg:pub.10.1007/s12149-018-1291-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106150181
    181 https://doi.org/10.1007/s12149-018-1291-7
    182 rdf:type schema:CreativeWork
    183 sg:pub.10.1007/s12149-018-1304-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1107121645
    184 https://doi.org/10.1007/s12149-018-1304-6
    185 rdf:type schema:CreativeWork
    186 sg:pub.10.1007/s12149-018-1312-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1109759418
    187 https://doi.org/10.1007/s12149-018-1312-6
    188 rdf:type schema:CreativeWork
    189 sg:pub.10.1007/s12149-018-1317-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1110227037
    190 https://doi.org/10.1007/s12149-018-1317-1
    191 rdf:type schema:CreativeWork
    192 grid-institutes:grid.412002.5 schema:alternateName Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takaramachi, 920-8641, Kanazawa, Ishikawa, Japan
    193 schema:name Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takaramachi, 920-8641, Kanazawa, Ishikawa, Japan
    194 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...